Guardant Health (GH) Tops Q4 EPS by 27c; offers guidance

Guardant Health (NASDAQ: GH) reported Q4 EPS of ($0.50), $0.27 better than the analyst estimate of ($0.77). Revenue for the quarter came in at $281.3 million versus the consensus estimate of $268.98 million.

GUIDANCE:

Guardant Health sees FY2026 revenue of $1.25-1.28 billion, versus the consensus of $1.242 billion.

For earnings history and earnings-related data on Guardant Health (GH) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results